BIOCONBSEBiocon LtdMinimalNeutral
Announced Sat, 9 May · 16:10 IST

Newspaper Advertisement - Financial Results

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+6.6%1-day move
₹378.70
prior close
₹380.45
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.1-1.0-0.3+0.3+6.6+9.9+10.4+13.7+12.8+14.6+10.0+10.0+9.0
Up moveDown movePending
AI summary

Biocon has published newspaper advertisements in Financial Express and Vijayavani (Kannada) on May 9, 2026, disclosing its Q4 and full-year FY2026 financial results. Consolidated revenue grew 11% to Rs 1,69,270 million vs Rs 1,52,617 million in FY2025. However, net profit attributable to shareholders dropped sharply to Rs 3,856 million from Rs 10,133 million — a 62% decline. Q4 standalone net profit was Rs 510 million vs Rs 6,093 million in the prior year. The statutory auditors (Sharp & Tannan) issued unqualified opinions. Results were reviewed by the Audit Committee and approved by the Board on May 7, 2026.

Likely market impact

The sharp drop in profitability despite higher revenue signals margin pressure, which could weigh on Biocon's stock price in the near term. Investors should monitor the upcoming postal ballot voting outcomes as multiple board changes and a preferential share issuance proposal could further influence sentiment.